Advertisement

Index by author

July 01, 1994; Volume 270,Issue 1

A

  1. Abrahams, T P

    1. The non-NMDA subtype of excitatory amino acid receptor plays the major role in control of cardiovascular function by the subretrofacial nucleus in cats.
      T P Abrahams, P J Hornby, K Chen, A M Dasilva and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 424-432;

  2. Adams, P

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
      S P Arneric, J P Sullivan, C A Briggs, D Donnelly-Roberts, D J Anderson, J L Raszkiewicz, M L Hughes, E D Cadman, P Adams and D S Garvey
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 310-318;

  3. Aguayo, L G

    1. Ethanol modulation of the gamma-aminobutyric acidA- and glycine-activated Cl- current in cultured mouse neurons.
      L G Aguayo and F C Pancetti
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 61-69;

  4. Akunne, H C

    1. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
      R B Rothman, J L Cadet, H C Akunne, M L Silverthorn, M H Baumann, F I Carroll, K C Rice, B R de Costa, J S Partilla and J B Wang
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 296-309;

  5. Albin, R L

    1. Quantitative autoradiography of [3H]t-butylbicycloorthobenzoate binding to the gamma-aminobutyric acid receptorA complex.
      S Y Sakurai, A Kume, D E Burdette and R L Albin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 362-370;

  6. Altiere, R J

    1. Pharmacological characterization of muscarinic receptors mediating acetylcholine-induced contraction and relaxation in rabbit intrapulmonary arteries.
      R J Altiere, D C Travis, J Roberts and D C Thompson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 269-276;

  7. Anderson, D J

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
      S P Arneric, J P Sullivan, C A Briggs, D Donnelly-Roberts, D J Anderson, J L Raszkiewicz, M L Hughes, E D Cadman, P Adams and D S Garvey
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 310-318;

  8. Angelastro, M R

    1. Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastase.
      S L Durham, C M Hare, M R Angelastro, J P Burkhart, J R Koehl, A L Marquart, S Mehdi, N P Peet and M J Janusz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 185-191;

  9. Ansay, M

    1. Modulation of the acetylcholine- and substance P-induced pulmonary edema by calcitonin gene-related peptide in the rabbit.
      A Delaunois, P Gustin and M Ansay
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 30-36;

  10. Arneric, S P

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
      S P Arneric, J P Sullivan, C A Briggs, D Donnelly-Roberts, D J Anderson, J L Raszkiewicz, M L Hughes, E D Cadman, P Adams and D S Garvey
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 310-318;

  11. Atack, J R

    1. Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers.
      J R Atack, A M Prior, S R Fletcher, K Quirk, R McKernan and C I Ragan
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 70-76;

  12. Aulakh, C S

    1. Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors.
      C S Aulakh, P Mazzola-Pomietto, K M Wozniak, J L Hill and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 127-132;

B

  1. Barker, F

    1. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.
      K S Pang, F Barker, A J Schwab and C A Goresky
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 285-295;

  2. Baumann, M H

    1. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
      R B Rothman, J L Cadet, H C Akunne, M L Silverthorn, M H Baumann, F I Carroll, K C Rice, B R de Costa, J S Partilla and J B Wang
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 296-309;

  3. Beard, D

    1. Enhanced elimination of biotinylated antibodies by avidin-based hemoperfusion in rats.
      K K Burkhart, D Beard and M L Billingsley
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 356-361;

  4. Belica, P S

    1. Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.
      R W Nims, R M McClain, P S Manchand, P S Belica, P E Thomas, D W Mellini, W E Utermahlen and R A Lubet
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 348-355;

  5. Bend, J R

    1. N-aralkylated derivatives of 1-aminobenzotriazole are potent isozyme- and lung-selective mechanism-based inhibitors of guinea pig cytochrome P-450 in vivo.
      L C Knickle, R M Philpot and J R Bend
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 377-385;

  6. Berryer, P

    1. Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo.
      J W Ryan, F A Valido, M J Sequeira, A Y Chung, P Berryer, X L Chen and J D Catravas
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 260-268;

  7. Berson, A

    1. Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen.
      A Berson, L Schmets, C Fisch, D Fau, C Wolf, B Fromenty, D Deschamps and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 167-176;

  8. Billingsley, M L

    1. Enhanced elimination of biotinylated antibodies by avidin-based hemoperfusion in rats.
      K K Burkhart, D Beard and M L Billingsley
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 356-361;

  9. Bixler, M A

    1. Effects of chlordiazepoxide, 8-OH-DPAT and ondansetron on radiation-induced decreases in food intake in rats.
      P J Winsauer, J F Verrees, K P O'Halloran, M A Bixler and P C Mele
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 142-149;

  10. Bochnowicz, S

    1. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
      D C Underwood, C J Kotzer, S Bochnowicz, R R Osborn, M A Luttmann, D W Hay and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 250-259;

  11. Bowen, W D

    1. Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice.
      Y Miyamoto, W D Bowen, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 37-39;

  12. Bralet, J

    1. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
      J Bralet, C Marie, C Mossiat, J M Lecomte, C Gros and J C Schwartz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 8-14;

  13. Breu, V

    1. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
      M Clozel, V Breu, G A Gray, B Kalina, B M Löffler, K Burri, J M Cassal, G Hirth, M Müller and W Neidhart
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 228-235;

  14. Briggs, C A

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
      S P Arneric, J P Sullivan, C A Briggs, D Donnelly-Roberts, D J Anderson, J L Raszkiewicz, M L Hughes, E D Cadman, P Adams and D S Garvey
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 310-318;

  15. Brioni, J D

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
      M W Decker, J D Brioni, J P Sullivan, M J Buckley, R J Radek, J L Raszkiewicz, C H Kang, D J Kim, W J Giardina and J T Wasicak
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 319-328;

  16. Brooks, D P

    1. Contribution of alpha-2 adrenoceptors to kappa opioid agonist-induced water diuresis in the rat.
      Y X Wang, G D Clarke, M Sbacchi, G Petrone and D P Brooks
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 244-249;

  17. Buckley, M J

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
      M W Decker, J D Brioni, J P Sullivan, M J Buckley, R J Radek, J L Raszkiewicz, C H Kang, D J Kim, W J Giardina and J T Wasicak
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 319-328;

  18. Buhi, W C

    1. Fetoplacental growth and placental protein synthesis in rats after chronic maternal cocaine administration.
      A S Salhab, C L DeVane, T Medrano, W C Buhi, I R Tebbett and K T Shiverick
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 392-398;

  19. Burdette, D E

    1. Quantitative autoradiography of [3H]t-butylbicycloorthobenzoate binding to the gamma-aminobutyric acid receptorA complex.
      S Y Sakurai, A Kume, D E Burdette and R L Albin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 362-370;

  20. Burkhart, J P

    1. Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastase.
      S L Durham, C M Hare, M R Angelastro, J P Burkhart, J R Koehl, A L Marquart, S Mehdi, N P Peet and M J Janusz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 185-191;

  21. Burkhart, K K

    1. Enhanced elimination of biotinylated antibodies by avidin-based hemoperfusion in rats.
      K K Burkhart, D Beard and M L Billingsley
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 356-361;

  22. Burri, K

    1. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
      M Clozel, V Breu, G A Gray, B Kalina, B M Löffler, K Burri, J M Cassal, G Hirth, M Müller and W Neidhart
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 228-235;

  23. Bushnell, P J

    1. Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance.
      P J Bushnell, K L Kelly and T R Ward
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 15-25;

C

  1. Cadet, J L

    1. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
      R B Rothman, J L Cadet, H C Akunne, M L Silverthorn, M H Baumann, F I Carroll, K C Rice, B R de Costa, J S Partilla and J B Wang
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 296-309;

  2. Cadman, E D

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
      S P Arneric, J P Sullivan, C A Briggs, D Donnelly-Roberts, D J Anderson, J L Raszkiewicz, M L Hughes, E D Cadman, P Adams and D S Garvey
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 310-318;

  3. Caine, S B

    1. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat.
      S B Caine and G F Koob
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 209-218;

  4. Carroll, F I

    1. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
      R B Rothman, J L Cadet, H C Akunne, M L Silverthorn, M H Baumann, F I Carroll, K C Rice, B R de Costa, J S Partilla and J B Wang
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 296-309;

  5. Cassal, J M

    1. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
      M Clozel, V Breu, G A Gray, B Kalina, B M Löffler, K Burri, J M Cassal, G Hirth, M Müller and W Neidhart
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 228-235;

  6. Catravas, J D

    1. Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo.
      J W Ryan, F A Valido, M J Sequeira, A Y Chung, P Berryer, X L Chen and J D Catravas
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 260-268;

  7. Cederbaum, A I

    1. Characterization of pyrazole and 4-methylpyrazole induction of cytochrome P4502E1 in rat kidney.
      D Wu and A I Cederbaum
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 407-413;

  8. Chen, K

    1. The non-NMDA subtype of excitatory amino acid receptor plays the major role in control of cardiovascular function by the subretrofacial nucleus in cats.
      T P Abrahams, P J Hornby, K Chen, A M Dasilva and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 424-432;

  9. Chen, X L

    1. Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo.
      J W Ryan, F A Valido, M J Sequeira, A Y Chung, P Berryer, X L Chen and J D Catravas
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 260-268;

  10. Cheney, D L

    1. Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizocilpine amnesia: putative role for allopregnanolone.
      E Romeo, D L Cheney, I Zivkovic, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 89-96;

  11. Chou, J M

    1. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
      P A Scott, J M Chou, H Tang and A Frazer
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 198-208;

  12. Chung, A Y

    1. Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo.
      J W Ryan, F A Valido, M J Sequeira, A Y Chung, P Berryer, X L Chen and J D Catravas
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 260-268;

  13. Clarke, G D

    1. Contribution of alpha-2 adrenoceptors to kappa opioid agonist-induced water diuresis in the rat.
      Y X Wang, G D Clarke, M Sbacchi, G Petrone and D P Brooks
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 244-249;

  14. Clozel, M

    1. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
      M Clozel, V Breu, G A Gray, B Kalina, B M Löffler, K Burri, J M Cassal, G Hirth, M Müller and W Neidhart
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 228-235;

  15. Compton, D R

    1. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
      P B Smith, D R Compton, S P Welch, R K Razdan, R Mechoulam and B R Martin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 219-227;

  16. Costa, E

    1. Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizocilpine amnesia: putative role for allopregnanolone.
      E Romeo, D L Cheney, I Zivkovic, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 89-96;

  17. Covert, R F

    1. Hemodynamic and cerebral blood flow effects of cocaine, cocaethylene and benzoylecgonine in conscious and anesthetized fetal lambs.
      R F Covert, M D Schreiber, I R Tebbett and L J Torgerson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 118-126;

  18. Cox, B M

    1. Opioids acting through delta receptors elicit a transient increase in the intracellular free calcium concentration in dorsal root ganglion-neuroblastoma hybrid ND8-47 cells.
      T Tang, J G Kiang and B M Cox
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 40-46;

  19. Cuadra, G

    1. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo.
      G Cuadra, K Summers and E Giacobini
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 277-284;

D

  1. Dasilva, A M

    1. The non-NMDA subtype of excitatory amino acid receptor plays the major role in control of cardiovascular function by the subretrofacial nucleus in cats.
      T P Abrahams, P J Hornby, K Chen, A M Dasilva and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 424-432;

  2. Decker, M W

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
      M W Decker, J D Brioni, J P Sullivan, M J Buckley, R J Radek, J L Raszkiewicz, C H Kang, D J Kim, W J Giardina and J T Wasicak
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 319-328;

  3. de Costa, B R

    1. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
      R B Rothman, J L Cadet, H C Akunne, M L Silverthorn, M H Baumann, F I Carroll, K C Rice, B R de Costa, J S Partilla and J B Wang
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 296-309;

  4. Delaunois, A

    1. Modulation of the acetylcholine- and substance P-induced pulmonary edema by calcitonin gene-related peptide in the rabbit.
      A Delaunois, P Gustin and M Ansay
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 30-36;

  5. Derakhchan, K

    1. Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia.
      K Derakhchan, P Pagé, C Lambert and T Kus
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 47-54;

  6. Deschamps, D

    1. Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen.
      A Berson, L Schmets, C Fisch, D Fau, C Wolf, B Fromenty, D Deschamps and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 167-176;

  7. DeVane, C L

    1. Fetoplacental growth and placental protein synthesis in rats after chronic maternal cocaine administration.
      A S Salhab, C L DeVane, T Medrano, W C Buhi, I R Tebbett and K T Shiverick
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 392-398;

  8. Domae, M

    1. Endothelins stimulate cyclic AMP accumulation in the isolated rat anterior pituitary gland: possible involvement of ETA receptor activation and prostaglandin E2 production.
      M Domae, K Yamada, T Inoue, M Satoh and T Furukawa
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 55-60;

  9. Donnelly-Roberts, D

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
      S P Arneric, J P Sullivan, C A Briggs, D Donnelly-Roberts, D J Anderson, J L Raszkiewicz, M L Hughes, E D Cadman, P Adams and D S Garvey
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 310-318;

  10. Dratman, M B

    1. An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy.
      J T Gordon, E E Tomlinson, J Greenberg and M B Dratman
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 111-117;

  11. Durham, S L

    1. Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastase.
      S L Durham, C M Hare, M R Angelastro, J P Burkhart, J R Koehl, A L Marquart, S Mehdi, N P Peet and M J Janusz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 185-191;

  12. Dutt, A

    1. Enhanced transepithelial flux of cimetidine by Madin-Darby canine kidney cells overexpressing human P-glycoprotein.
      B F Pan, A Dutt and J A Nelson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 1-7;

E

  1. Evans, W E

    1. Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans.
      H L McLeod, L Fang, X Luo, E P Scott and W E Evans
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 26-29;

F

  1. Fang, L

    1. Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans.
      H L McLeod, L Fang, X Luo, E P Scott and W E Evans
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 26-29;

  2. Fau, D

    1. Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen.
      A Berson, L Schmets, C Fisch, D Fau, C Wolf, B Fromenty, D Deschamps and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 167-176;

  3. Ferrer, I

    1. Diarrhea associated with intestinal inflammation increases the potency of mu and delta opioids on the inhibition of gastrointestinal transit in mice.
      O Pol, I Ferrer and M M Puig
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 386-391;

  4. Fisch, C

    1. Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen.
      A Berson, L Schmets, C Fisch, D Fau, C Wolf, B Fromenty, D Deschamps and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 167-176;

  5. Fletcher, S R

    1. Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers.
      J R Atack, A M Prior, S R Fletcher, K Quirk, R McKernan and C I Ragan
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 70-76;

  6. Forkert, P G

    1. In vitro biotransformation of 1,1-dichloroethylene by hepatic cytochrome P-450 2E1 in mice.
      R P Lee and P G Forkert
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 371-376;

  7. Fournie-Zaluski, M C

    1. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
      O Valverde, R Maldonado, M C Fournie-Zaluski and B P Roques
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 77-88;

  8. Frazer, A

    1. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
      P A Scott, J M Chou, H Tang and A Frazer
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 198-208;

  9. Fromenty, B

    1. Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen.
      A Berson, L Schmets, C Fisch, D Fau, C Wolf, B Fromenty, D Deschamps and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 167-176;

  10. Furukawa, T

    1. Endothelins stimulate cyclic AMP accumulation in the isolated rat anterior pituitary gland: possible involvement of ETA receptor activation and prostaglandin E2 production.
      M Domae, K Yamada, T Inoue, M Satoh and T Furukawa
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 55-60;

G

  1. Gareau, Y

    1. Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung.
      K M Metters, Y Gareau, A Lord, C Rochette and N Sawyer
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 399-406;

  2. Garvey, D S

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
      S P Arneric, J P Sullivan, C A Briggs, D Donnelly-Roberts, D J Anderson, J L Raszkiewicz, M L Hughes, E D Cadman, P Adams and D S Garvey
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 310-318;

  3. Giacobini, E

    1. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo.
      G Cuadra, K Summers and E Giacobini
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 277-284;

  4. Giardina, W J

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
      M W Decker, J D Brioni, J P Sullivan, M J Buckley, R J Radek, J L Raszkiewicz, C H Kang, D J Kim, W J Giardina and J T Wasicak
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 319-328;

  5. Gibb, J W

    1. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
      S P Gygi, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 192-197;
    2. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
      M Johnson, P K Sonsalla, A A Letter, G R Hanson and J W Gibb
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 97-103;

  6. Gillis, R A

    1. The non-NMDA subtype of excitatory amino acid receptor plays the major role in control of cardiovascular function by the subretrofacial nucleus in cats.
      T P Abrahams, P J Hornby, K Chen, A M Dasilva and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 424-432;

  7. Gordon, J T

    1. An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy.
      J T Gordon, E E Tomlinson, J Greenberg and M B Dratman
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 111-117;

  8. Goresky, C A

    1. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.
      K S Pang, F Barker, A J Schwab and C A Goresky
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 285-295;

  9. Goto, S

    1. Stereoselective renal tubular secretion of an organic anion in the isolated perfused rat kidney.
      K Higaki, K Kadono, S Goto and M Nakano
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 329-335;

  10. Gray, G A

    1. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
      M Clozel, V Breu, G A Gray, B Kalina, B M Löffler, K Burri, J M Cassal, G Hirth, M Müller and W Neidhart
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 228-235;

  11. Greenberg, J

    1. An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy.
      J T Gordon, E E Tomlinson, J Greenberg and M B Dratman
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 111-117;

  12. Grider, J R

    1. Coexistence of three tachykinin receptors coupled to Ca++ signaling pathways in intestinal muscle cells.
      P M Hellstrom, K S Murthy, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 236-243;

  13. Gros, C

    1. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
      J Bralet, C Marie, C Mossiat, J M Lecomte, C Gros and J C Schwartz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 8-14;

  14. Guengerich, F P

    1. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
      T Shimada, H Yamazaki, M Mimura, Y Inui and F P Guengerich
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 414-423;

  15. Guidotti, A

    1. Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizocilpine amnesia: putative role for allopregnanolone.
      E Romeo, D L Cheney, I Zivkovic, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 89-96;

  16. Gustin, P

    1. Modulation of the acetylcholine- and substance P-induced pulmonary edema by calcitonin gene-related peptide in the rabbit.
      A Delaunois, P Gustin and M Ansay
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 30-36;

  17. Gygi, S P

    1. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
      S P Gygi, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 192-197;

H

  1. Hanson, G R

    1. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
      S P Gygi, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 192-197;
    2. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
      M Johnson, P K Sonsalla, A A Letter, G R Hanson and J W Gibb
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 97-103;

  2. Hare, C M

    1. Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastase.
      S L Durham, C M Hare, M R Angelastro, J P Burkhart, J R Koehl, A L Marquart, S Mehdi, N P Peet and M J Janusz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 185-191;

  3. Hasegawa, J

    1. Aquaretic effect of the stable dynorphin-A analog E2078 in the human.
      A Ohnishi, M Mihara, S Yasuda, Y Tomono, J Hasegawa and T Tanaka
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 342-347;

  4. Hay, D W

    1. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
      D C Underwood, C J Kotzer, S Bochnowicz, R R Osborn, M A Luttmann, D W Hay and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 250-259;

  5. Hellstrom, P M

    1. Coexistence of three tachykinin receptors coupled to Ca++ signaling pathways in intestinal muscle cells.
      P M Hellstrom, K S Murthy, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 236-243;

  6. Higaki, K

    1. Stereoselective renal tubular secretion of an organic anion in the isolated perfused rat kidney.
      K Higaki, K Kadono, S Goto and M Nakano
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 329-335;

  7. Hill, J L

    1. Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors.
      C S Aulakh, P Mazzola-Pomietto, K M Wozniak, J L Hill and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 127-132;

  8. Hirth, G

    1. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
      M Clozel, V Breu, G A Gray, B Kalina, B M Löffler, K Burri, J M Cassal, G Hirth, M Müller and W Neidhart
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 228-235;

  9. Hornby, P J

    1. The non-NMDA subtype of excitatory amino acid receptor plays the major role in control of cardiovascular function by the subretrofacial nucleus in cats.
      T P Abrahams, P J Hornby, K Chen, A M Dasilva and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 424-432;

  10. Hughes, M L

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
      S P Arneric, J P Sullivan, C A Briggs, D Donnelly-Roberts, D J Anderson, J L Raszkiewicz, M L Hughes, E D Cadman, P Adams and D S Garvey
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 310-318;

I

  1. Inoue, T

    1. Endothelins stimulate cyclic AMP accumulation in the isolated rat anterior pituitary gland: possible involvement of ETA receptor activation and prostaglandin E2 production.
      M Domae, K Yamada, T Inoue, M Satoh and T Furukawa
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 55-60;

  2. Inui, Y

    1. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
      T Shimada, H Yamazaki, M Mimura, Y Inui and F P Guengerich
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 414-423;

  3. Isosaki, M

    1. Pharmacological evidence for regulation of Na(+)-Ca++ exchange by Ca++/calmodulin-dependent protein kinase in isolated bovine adrenal medullary cells.
      M Isosaki, N Minami and T Nakashima
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 104-110;

  4. Izu, L T

    1. Chronic ethanol exposure inhibits ATP-stimulated but not KCl-stimulated dopamine release in PC 12 cells.
      W K Kim, R G Johnson, L T Izu and R A Rabin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 336-341;

J

  1. Janusz, M J

    1. Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastase.
      S L Durham, C M Hare, M R Angelastro, J P Burkhart, J R Koehl, A L Marquart, S Mehdi, N P Peet and M J Janusz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 185-191;

  2. Johnson, M

    1. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
      M Johnson, P K Sonsalla, A A Letter, G R Hanson and J W Gibb
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 97-103;

  3. Johnson, R G

    1. Chronic ethanol exposure inhibits ATP-stimulated but not KCl-stimulated dopamine release in PC 12 cells.
      W K Kim, R G Johnson, L T Izu and R A Rabin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 336-341;

K

  1. Kadono, K

    1. Stereoselective renal tubular secretion of an organic anion in the isolated perfused rat kidney.
      K Higaki, K Kadono, S Goto and M Nakano
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 329-335;

  2. Kalina, B

    1. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
      M Clozel, V Breu, G A Gray, B Kalina, B M Löffler, K Burri, J M Cassal, G Hirth, M Müller and W Neidhart
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 228-235;

  3. Kang, C H

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
      M W Decker, J D Brioni, J P Sullivan, M J Buckley, R J Radek, J L Raszkiewicz, C H Kang, D J Kim, W J Giardina and J T Wasicak
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 319-328;

  4. Kelly, K L

    1. Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance.
      P J Bushnell, K L Kelly and T R Ward
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 15-25;

  5. Khan, I M

    1. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
      I M Khan, P Taylor and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 150-158;
    2. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
      I M Khan, T L Yaksh and P Taylor
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 159-166;

  6. Kiang, J G

    1. Opioids acting through delta receptors elicit a transient increase in the intracellular free calcium concentration in dorsal root ganglion-neuroblastoma hybrid ND8-47 cells.
      T Tang, J G Kiang and B M Cox
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 40-46;

  7. Kim, D J

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
      M W Decker, J D Brioni, J P Sullivan, M J Buckley, R J Radek, J L Raszkiewicz, C H Kang, D J Kim, W J Giardina and J T Wasicak
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 319-328;

  8. Kim, W K

    1. Chronic ethanol exposure inhibits ATP-stimulated but not KCl-stimulated dopamine release in PC 12 cells.
      W K Kim, R G Johnson, L T Izu and R A Rabin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 336-341;

  9. Knickle, L C

    1. N-aralkylated derivatives of 1-aminobenzotriazole are potent isozyme- and lung-selective mechanism-based inhibitors of guinea pig cytochrome P-450 in vivo.
      L C Knickle, R M Philpot and J R Bend
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 377-385;

  10. Koehl, J R

    1. Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastase.
      S L Durham, C M Hare, M R Angelastro, J P Burkhart, J R Koehl, A L Marquart, S Mehdi, N P Peet and M J Janusz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 185-191;

  11. Koob, G F

    1. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat.
      S B Caine and G F Koob
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 209-218;

  12. Kotzer, C J

    1. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
      D C Underwood, C J Kotzer, S Bochnowicz, R R Osborn, M A Luttmann, D W Hay and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 250-259;

  13. Kume, A

    1. Quantitative autoradiography of [3H]t-butylbicycloorthobenzoate binding to the gamma-aminobutyric acid receptorA complex.
      S Y Sakurai, A Kume, D E Burdette and R L Albin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 362-370;

  14. Kus, T

    1. Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia.
      K Derakhchan, P Pagé, C Lambert and T Kus
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 47-54;

L

  1. Lambert, C

    1. Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia.
      K Derakhchan, P Pagé, C Lambert and T Kus
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 47-54;

  2. Law, P Y

    1. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
      P L Prather, A W Tsai and P Y Law
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 177-184;

  3. Lecomte, J M

    1. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
      J Bralet, C Marie, C Mossiat, J M Lecomte, C Gros and J C Schwartz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 8-14;

  4. Lee, R P

    1. In vitro biotransformation of 1,1-dichloroethylene by hepatic cytochrome P-450 2E1 in mice.
      R P Lee and P G Forkert
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 371-376;

  5. Letter, A A

    1. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
      M Johnson, P K Sonsalla, A A Letter, G R Hanson and J W Gibb
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 97-103;

  6. Löffler, B M

    1. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
      M Clozel, V Breu, G A Gray, B Kalina, B M Löffler, K Burri, J M Cassal, G Hirth, M Müller and W Neidhart
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 228-235;

  7. Lord, A

    1. Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung.
      K M Metters, Y Gareau, A Lord, C Rochette and N Sawyer
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 399-406;

  8. Lubet, R A

    1. Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.
      R W Nims, R M McClain, P S Manchand, P S Belica, P E Thomas, D W Mellini, W E Utermahlen and R A Lubet
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 348-355;

  9. Luo, X

    1. Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans.
      H L McLeod, L Fang, X Luo, E P Scott and W E Evans
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 26-29;

  10. Luttmann, M A

    1. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
      D C Underwood, C J Kotzer, S Bochnowicz, R R Osborn, M A Luttmann, D W Hay and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 250-259;

M

  1. Makhlouf, G M

    1. Coexistence of three tachykinin receptors coupled to Ca++ signaling pathways in intestinal muscle cells.
      P M Hellstrom, K S Murthy, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 236-243;

  2. Maldonado, R

    1. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
      O Valverde, R Maldonado, M C Fournie-Zaluski and B P Roques
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 77-88;

  3. Manchand, P S

    1. Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.
      R W Nims, R M McClain, P S Manchand, P S Belica, P E Thomas, D W Mellini, W E Utermahlen and R A Lubet
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 348-355;

  4. Marie, C

    1. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
      J Bralet, C Marie, C Mossiat, J M Lecomte, C Gros and J C Schwartz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 8-14;

  5. Marquart, A L

    1. Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastase.
      S L Durham, C M Hare, M R Angelastro, J P Burkhart, J R Koehl, A L Marquart, S Mehdi, N P Peet and M J Janusz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 185-191;

  6. Martin, B R

    1. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
      P B Smith, D R Compton, S P Welch, R K Razdan, R Mechoulam and B R Martin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 219-227;

  7. Masserano, J M

    1. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
      J M Masserano, D Venable and R J Wyatt
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 133-141;

  8. Mazzola-Pomietto, P

    1. Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors.
      C S Aulakh, P Mazzola-Pomietto, K M Wozniak, J L Hill and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 127-132;

  9. McClain, R M

    1. Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.
      R W Nims, R M McClain, P S Manchand, P S Belica, P E Thomas, D W Mellini, W E Utermahlen and R A Lubet
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 348-355;

  10. McKernan, R

    1. Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers.
      J R Atack, A M Prior, S R Fletcher, K Quirk, R McKernan and C I Ragan
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 70-76;

  11. McLeod, H L

    1. Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans.
      H L McLeod, L Fang, X Luo, E P Scott and W E Evans
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 26-29;

  12. Mechoulam, R

    1. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
      P B Smith, D R Compton, S P Welch, R K Razdan, R Mechoulam and B R Martin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 219-227;

  13. Medrano, T

    1. Fetoplacental growth and placental protein synthesis in rats after chronic maternal cocaine administration.
      A S Salhab, C L DeVane, T Medrano, W C Buhi, I R Tebbett and K T Shiverick
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 392-398;

  14. Mehdi, S

    1. Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastase.
      S L Durham, C M Hare, M R Angelastro, J P Burkhart, J R Koehl, A L Marquart, S Mehdi, N P Peet and M J Janusz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 185-191;

  15. Mele, P C

    1. Effects of chlordiazepoxide, 8-OH-DPAT and ondansetron on radiation-induced decreases in food intake in rats.
      P J Winsauer, J F Verrees, K P O'Halloran, M A Bixler and P C Mele
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 142-149;

  16. Mellini, D W

    1. Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.
      R W Nims, R M McClain, P S Manchand, P S Belica, P E Thomas, D W Mellini, W E Utermahlen and R A Lubet
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 348-355;

  17. Metters, K M

    1. Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung.
      K M Metters, Y Gareau, A Lord, C Rochette and N Sawyer
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 399-406;

  18. Mihara, M

    1. Aquaretic effect of the stable dynorphin-A analog E2078 in the human.
      A Ohnishi, M Mihara, S Yasuda, Y Tomono, J Hasegawa and T Tanaka
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 342-347;

  19. Mimura, M

    1. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
      T Shimada, H Yamazaki, M Mimura, Y Inui and F P Guengerich
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 414-423;

  20. Minami, N

    1. Pharmacological evidence for regulation of Na(+)-Ca++ exchange by Ca++/calmodulin-dependent protein kinase in isolated bovine adrenal medullary cells.
      M Isosaki, N Minami and T Nakashima
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 104-110;

  21. Miyamoto, Y

    1. Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice.
      Y Miyamoto, W D Bowen, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 37-39;

  22. Mossiat, C

    1. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
      J Bralet, C Marie, C Mossiat, J M Lecomte, C Gros and J C Schwartz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 8-14;

  23. Müller, M

    1. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
      M Clozel, V Breu, G A Gray, B Kalina, B M Löffler, K Burri, J M Cassal, G Hirth, M Müller and W Neidhart
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 228-235;

  24. Murphy, D L

    1. Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors.
      C S Aulakh, P Mazzola-Pomietto, K M Wozniak, J L Hill and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 127-132;

  25. Murthy, K S

    1. Coexistence of three tachykinin receptors coupled to Ca++ signaling pathways in intestinal muscle cells.
      P M Hellstrom, K S Murthy, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 236-243;

N

  1. Nakano, M

    1. Stereoselective renal tubular secretion of an organic anion in the isolated perfused rat kidney.
      K Higaki, K Kadono, S Goto and M Nakano
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 329-335;

  2. Nakashima, T

    1. Pharmacological evidence for regulation of Na(+)-Ca++ exchange by Ca++/calmodulin-dependent protein kinase in isolated bovine adrenal medullary cells.
      M Isosaki, N Minami and T Nakashima
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 104-110;

  3. Neidhart, W

    1. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
      M Clozel, V Breu, G A Gray, B Kalina, B M Löffler, K Burri, J M Cassal, G Hirth, M Müller and W Neidhart
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 228-235;

  4. Nelson, J A

    1. Enhanced transepithelial flux of cimetidine by Madin-Darby canine kidney cells overexpressing human P-glycoprotein.
      B F Pan, A Dutt and J A Nelson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 1-7;

  5. Nims, R W

    1. Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.
      R W Nims, R M McClain, P S Manchand, P S Belica, P E Thomas, D W Mellini, W E Utermahlen and R A Lubet
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 348-355;

O

  1. O'Halloran, K P

    1. Effects of chlordiazepoxide, 8-OH-DPAT and ondansetron on radiation-induced decreases in food intake in rats.
      P J Winsauer, J F Verrees, K P O'Halloran, M A Bixler and P C Mele
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 142-149;

  2. Ohnishi, A

    1. Aquaretic effect of the stable dynorphin-A analog E2078 in the human.
      A Ohnishi, M Mihara, S Yasuda, Y Tomono, J Hasegawa and T Tanaka
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 342-347;

  3. Osborn, R R

    1. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
      D C Underwood, C J Kotzer, S Bochnowicz, R R Osborn, M A Luttmann, D W Hay and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 250-259;

P

  1. Pagé, P

    1. Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia.
      K Derakhchan, P Pagé, C Lambert and T Kus
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 47-54;

  2. Pan, B F

    1. Enhanced transepithelial flux of cimetidine by Madin-Darby canine kidney cells overexpressing human P-glycoprotein.
      B F Pan, A Dutt and J A Nelson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 1-7;

  3. Pancetti, F C

    1. Ethanol modulation of the gamma-aminobutyric acidA- and glycine-activated Cl- current in cultured mouse neurons.
      L G Aguayo and F C Pancetti
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 61-69;

  4. Pang, K S

    1. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.
      K S Pang, F Barker, A J Schwab and C A Goresky
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 285-295;

  5. Partilla, J S

    1. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
      R B Rothman, J L Cadet, H C Akunne, M L Silverthorn, M H Baumann, F I Carroll, K C Rice, B R de Costa, J S Partilla and J B Wang
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 296-309;

  6. Peet, N P

    1. Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastase.
      S L Durham, C M Hare, M R Angelastro, J P Burkhart, J R Koehl, A L Marquart, S Mehdi, N P Peet and M J Janusz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 185-191;

  7. Pessayre, D

    1. Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen.
      A Berson, L Schmets, C Fisch, D Fau, C Wolf, B Fromenty, D Deschamps and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 167-176;

  8. Petrone, G

    1. Contribution of alpha-2 adrenoceptors to kappa opioid agonist-induced water diuresis in the rat.
      Y X Wang, G D Clarke, M Sbacchi, G Petrone and D P Brooks
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 244-249;

  9. Philpot, R M

    1. N-aralkylated derivatives of 1-aminobenzotriazole are potent isozyme- and lung-selective mechanism-based inhibitors of guinea pig cytochrome P-450 in vivo.
      L C Knickle, R M Philpot and J R Bend
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 377-385;

  10. Pol, O

    1. Diarrhea associated with intestinal inflammation increases the potency of mu and delta opioids on the inhibition of gastrointestinal transit in mice.
      O Pol, I Ferrer and M M Puig
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 386-391;

  11. Portoghese, P S

    1. Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice.
      Y Miyamoto, W D Bowen, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 37-39;

  12. Prather, P L

    1. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
      P L Prather, A W Tsai and P Y Law
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 177-184;

  13. Prior, A M

    1. Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers.
      J R Atack, A M Prior, S R Fletcher, K Quirk, R McKernan and C I Ragan
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 70-76;

  14. Puig, M M

    1. Diarrhea associated with intestinal inflammation increases the potency of mu and delta opioids on the inhibition of gastrointestinal transit in mice.
      O Pol, I Ferrer and M M Puig
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 386-391;

Q

  1. Quirk, K

    1. Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers.
      J R Atack, A M Prior, S R Fletcher, K Quirk, R McKernan and C I Ragan
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 70-76;

R

  1. Rabin, R A

    1. Chronic ethanol exposure inhibits ATP-stimulated but not KCl-stimulated dopamine release in PC 12 cells.
      W K Kim, R G Johnson, L T Izu and R A Rabin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 336-341;

  2. Radek, R J

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
      M W Decker, J D Brioni, J P Sullivan, M J Buckley, R J Radek, J L Raszkiewicz, C H Kang, D J Kim, W J Giardina and J T Wasicak
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 319-328;

  3. Ragan, C I

    1. Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers.
      J R Atack, A M Prior, S R Fletcher, K Quirk, R McKernan and C I Ragan
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 70-76;

  4. Raszkiewicz, J L

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
      S P Arneric, J P Sullivan, C A Briggs, D Donnelly-Roberts, D J Anderson, J L Raszkiewicz, M L Hughes, E D Cadman, P Adams and D S Garvey
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 310-318;
    2. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
      M W Decker, J D Brioni, J P Sullivan, M J Buckley, R J Radek, J L Raszkiewicz, C H Kang, D J Kim, W J Giardina and J T Wasicak
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 319-328;

  5. Razdan, R K

    1. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
      P B Smith, D R Compton, S P Welch, R K Razdan, R Mechoulam and B R Martin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 219-227;

  6. Rice, K C

    1. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
      R B Rothman, J L Cadet, H C Akunne, M L Silverthorn, M H Baumann, F I Carroll, K C Rice, B R de Costa, J S Partilla and J B Wang
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 296-309;

  7. Roberts, J

    1. Pharmacological characterization of muscarinic receptors mediating acetylcholine-induced contraction and relaxation in rabbit intrapulmonary arteries.
      R J Altiere, D C Travis, J Roberts and D C Thompson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 269-276;

  8. Rochette, C

    1. Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung.
      K M Metters, Y Gareau, A Lord, C Rochette and N Sawyer
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 399-406;

  9. Romeo, E

    1. Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizocilpine amnesia: putative role for allopregnanolone.
      E Romeo, D L Cheney, I Zivkovic, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 89-96;

  10. Roques, B P

    1. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
      O Valverde, R Maldonado, M C Fournie-Zaluski and B P Roques
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 77-88;

  11. Rothman, R B

    1. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
      R B Rothman, J L Cadet, H C Akunne, M L Silverthorn, M H Baumann, F I Carroll, K C Rice, B R de Costa, J S Partilla and J B Wang
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 296-309;

  12. Ryan, J W

    1. Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo.
      J W Ryan, F A Valido, M J Sequeira, A Y Chung, P Berryer, X L Chen and J D Catravas
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 260-268;

S

  1. Sakurai, S Y

    1. Quantitative autoradiography of [3H]t-butylbicycloorthobenzoate binding to the gamma-aminobutyric acid receptorA complex.
      S Y Sakurai, A Kume, D E Burdette and R L Albin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 362-370;

  2. Salhab, A S

    1. Fetoplacental growth and placental protein synthesis in rats after chronic maternal cocaine administration.
      A S Salhab, C L DeVane, T Medrano, W C Buhi, I R Tebbett and K T Shiverick
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 392-398;

  3. Satoh, M

    1. Endothelins stimulate cyclic AMP accumulation in the isolated rat anterior pituitary gland: possible involvement of ETA receptor activation and prostaglandin E2 production.
      M Domae, K Yamada, T Inoue, M Satoh and T Furukawa
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 55-60;

  4. Sawyer, N

    1. Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung.
      K M Metters, Y Gareau, A Lord, C Rochette and N Sawyer
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 399-406;

  5. Sbacchi, M

    1. Contribution of alpha-2 adrenoceptors to kappa opioid agonist-induced water diuresis in the rat.
      Y X Wang, G D Clarke, M Sbacchi, G Petrone and D P Brooks
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 244-249;

  6. Schmets, L

    1. Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen.
      A Berson, L Schmets, C Fisch, D Fau, C Wolf, B Fromenty, D Deschamps and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 167-176;

  7. Schreiber, M D

    1. Hemodynamic and cerebral blood flow effects of cocaine, cocaethylene and benzoylecgonine in conscious and anesthetized fetal lambs.
      R F Covert, M D Schreiber, I R Tebbett and L J Torgerson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 118-126;

  8. Schwab, A J

    1. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.
      K S Pang, F Barker, A J Schwab and C A Goresky
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 285-295;

  9. Schwartz, J C

    1. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
      J Bralet, C Marie, C Mossiat, J M Lecomte, C Gros and J C Schwartz
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 8-14;

  10. Scott, E P

    1. Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans.
      H L McLeod, L Fang, X Luo, E P Scott and W E Evans
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 26-29;

  11. Scott, P A

    1. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
      P A Scott, J M Chou, H Tang and A Frazer
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 198-208;

  12. Sequeira, M J

    1. Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo.
      J W Ryan, F A Valido, M J Sequeira, A Y Chung, P Berryer, X L Chen and J D Catravas
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 260-268;

  13. Shimada, T

    1. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
      T Shimada, H Yamazaki, M Mimura, Y Inui and F P Guengerich
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 414-423;

  14. Shiverick, K T

    1. Fetoplacental growth and placental protein synthesis in rats after chronic maternal cocaine administration.
      A S Salhab, C L DeVane, T Medrano, W C Buhi, I R Tebbett and K T Shiverick
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 392-398;

  15. Silverthorn, M L

    1. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
      R B Rothman, J L Cadet, H C Akunne, M L Silverthorn, M H Baumann, F I Carroll, K C Rice, B R de Costa, J S Partilla and J B Wang
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 296-309;

  16. Smith, P B

    1. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
      P B Smith, D R Compton, S P Welch, R K Razdan, R Mechoulam and B R Martin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 219-227;

  17. Sonsalla, P K

    1. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
      M Johnson, P K Sonsalla, A A Letter, G R Hanson and J W Gibb
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 97-103;

  18. Sullivan, J P

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
      S P Arneric, J P Sullivan, C A Briggs, D Donnelly-Roberts, D J Anderson, J L Raszkiewicz, M L Hughes, E D Cadman, P Adams and D S Garvey
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 310-318;
    2. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
      M W Decker, J D Brioni, J P Sullivan, M J Buckley, R J Radek, J L Raszkiewicz, C H Kang, D J Kim, W J Giardina and J T Wasicak
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 319-328;

  19. Summers, K

    1. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo.
      G Cuadra, K Summers and E Giacobini
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 277-284;

T

  1. Takemori, A E

    1. Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice.
      Y Miyamoto, W D Bowen, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 37-39;

  2. Tanaka, T

    1. Aquaretic effect of the stable dynorphin-A analog E2078 in the human.
      A Ohnishi, M Mihara, S Yasuda, Y Tomono, J Hasegawa and T Tanaka
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 342-347;

  3. Tang, H

    1. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
      P A Scott, J M Chou, H Tang and A Frazer
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 198-208;

  4. Tang, T

    1. Opioids acting through delta receptors elicit a transient increase in the intracellular free calcium concentration in dorsal root ganglion-neuroblastoma hybrid ND8-47 cells.
      T Tang, J G Kiang and B M Cox
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 40-46;

  5. Taylor, P

    1. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
      I M Khan, P Taylor and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 150-158;
    2. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
      I M Khan, T L Yaksh and P Taylor
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 159-166;

  6. Tebbett, I R

    1. Hemodynamic and cerebral blood flow effects of cocaine, cocaethylene and benzoylecgonine in conscious and anesthetized fetal lambs.
      R F Covert, M D Schreiber, I R Tebbett and L J Torgerson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 118-126;
    2. Fetoplacental growth and placental protein synthesis in rats after chronic maternal cocaine administration.
      A S Salhab, C L DeVane, T Medrano, W C Buhi, I R Tebbett and K T Shiverick
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 392-398;

  7. Thomas, P E

    1. Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.
      R W Nims, R M McClain, P S Manchand, P S Belica, P E Thomas, D W Mellini, W E Utermahlen and R A Lubet
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 348-355;

  8. Thompson, D C

    1. Pharmacological characterization of muscarinic receptors mediating acetylcholine-induced contraction and relaxation in rabbit intrapulmonary arteries.
      R J Altiere, D C Travis, J Roberts and D C Thompson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 269-276;

  9. Tomlinson, E E

    1. An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy.
      J T Gordon, E E Tomlinson, J Greenberg and M B Dratman
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 111-117;

  10. Tomono, Y

    1. Aquaretic effect of the stable dynorphin-A analog E2078 in the human.
      A Ohnishi, M Mihara, S Yasuda, Y Tomono, J Hasegawa and T Tanaka
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 342-347;

  11. Torgerson, L J

    1. Hemodynamic and cerebral blood flow effects of cocaine, cocaethylene and benzoylecgonine in conscious and anesthetized fetal lambs.
      R F Covert, M D Schreiber, I R Tebbett and L J Torgerson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 118-126;

  12. Torphy, T J

    1. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
      D C Underwood, C J Kotzer, S Bochnowicz, R R Osborn, M A Luttmann, D W Hay and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 250-259;

  13. Travis, D C

    1. Pharmacological characterization of muscarinic receptors mediating acetylcholine-induced contraction and relaxation in rabbit intrapulmonary arteries.
      R J Altiere, D C Travis, J Roberts and D C Thompson
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 269-276;

  14. Tsai, A W

    1. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
      P L Prather, A W Tsai and P Y Law
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 177-184;

U

  1. Underwood, D C

    1. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
      D C Underwood, C J Kotzer, S Bochnowicz, R R Osborn, M A Luttmann, D W Hay and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 250-259;

  2. Utermahlen, W E

    1. Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.
      R W Nims, R M McClain, P S Manchand, P S Belica, P E Thomas, D W Mellini, W E Utermahlen and R A Lubet
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 348-355;

V

  1. Valido, F A

    1. Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo.
      J W Ryan, F A Valido, M J Sequeira, A Y Chung, P Berryer, X L Chen and J D Catravas
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 260-268;

  2. Valverde, O

    1. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
      O Valverde, R Maldonado, M C Fournie-Zaluski and B P Roques
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 77-88;

  3. Venable, D

    1. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
      J M Masserano, D Venable and R J Wyatt
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 133-141;

  4. Verrees, J F

    1. Effects of chlordiazepoxide, 8-OH-DPAT and ondansetron on radiation-induced decreases in food intake in rats.
      P J Winsauer, J F Verrees, K P O'Halloran, M A Bixler and P C Mele
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 142-149;

W

  1. Wang, J B

    1. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
      R B Rothman, J L Cadet, H C Akunne, M L Silverthorn, M H Baumann, F I Carroll, K C Rice, B R de Costa, J S Partilla and J B Wang
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 296-309;

  2. Wang, Y X

    1. Contribution of alpha-2 adrenoceptors to kappa opioid agonist-induced water diuresis in the rat.
      Y X Wang, G D Clarke, M Sbacchi, G Petrone and D P Brooks
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 244-249;

  3. Ward, T R

    1. Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance.
      P J Bushnell, K L Kelly and T R Ward
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 15-25;

  4. Wasicak, J T

    1. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
      M W Decker, J D Brioni, J P Sullivan, M J Buckley, R J Radek, J L Raszkiewicz, C H Kang, D J Kim, W J Giardina and J T Wasicak
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 319-328;

  5. Welch, S P

    1. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
      P B Smith, D R Compton, S P Welch, R K Razdan, R Mechoulam and B R Martin
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 219-227;

  6. Winsauer, P J

    1. Effects of chlordiazepoxide, 8-OH-DPAT and ondansetron on radiation-induced decreases in food intake in rats.
      P J Winsauer, J F Verrees, K P O'Halloran, M A Bixler and P C Mele
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 142-149;

  7. Wolf, C

    1. Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen.
      A Berson, L Schmets, C Fisch, D Fau, C Wolf, B Fromenty, D Deschamps and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 167-176;

  8. Wozniak, K M

    1. Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors.
      C S Aulakh, P Mazzola-Pomietto, K M Wozniak, J L Hill and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 127-132;

  9. Wu, D

    1. Characterization of pyrazole and 4-methylpyrazole induction of cytochrome P4502E1 in rat kidney.
      D Wu and A I Cederbaum
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 407-413;

  10. Wyatt, R J

    1. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
      J M Masserano, D Venable and R J Wyatt
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 133-141;

Y

  1. Yaksh, T L

    1. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
      I M Khan, P Taylor and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 150-158;
    2. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
      I M Khan, T L Yaksh and P Taylor
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 159-166;

  2. Yamada, K

    1. Endothelins stimulate cyclic AMP accumulation in the isolated rat anterior pituitary gland: possible involvement of ETA receptor activation and prostaglandin E2 production.
      M Domae, K Yamada, T Inoue, M Satoh and T Furukawa
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 55-60;

  3. Yamazaki, H

    1. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
      T Shimada, H Yamazaki, M Mimura, Y Inui and F P Guengerich
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 414-423;

  4. Yasuda, S

    1. Aquaretic effect of the stable dynorphin-A analog E2078 in the human.
      A Ohnishi, M Mihara, S Yasuda, Y Tomono, J Hasegawa and T Tanaka
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 342-347;

Z

  1. Zivkovic, I

    1. Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizocilpine amnesia: putative role for allopregnanolone.
      E Romeo, D L Cheney, I Zivkovic, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 89-96;
Back to top

In this issue